BLUE : Insider Transactions for Bluebird Bio, Inc. | J3SG

Sign in:	Email	Password save:

		Company Reports
Find Symbol

Recent: Companies Filers Institutions

Membership is free, please Sign Up.

My Recent Searches

Help

Roster

Institutions

Add To Portfolo/Alerts

Get Insiders for :

Bluebird Bio, Inc. (BLUE)

$1.02

0.04 (3.77%) as of 4:30 Mon 5/13

Download

Exchange:

N/A

Security Type:

Common

Shares Out:

139,126,000

Market Cap:

141.91(M)

Last Volume:

0

Avg Vol:

0

52 Week Range:

$0.8871 - $4.83

Level I Sector:

Health Care

Level II Sector:

Drugs

Level III Sector:

Biotechnology

Member Indexes:

Rankings:

Insider 3 Months : -

Insider 6 Months : -

Insider 3/6 Months : -

Guru Rank Number : -

Guru Rank Value : -

Guru Occurances : -


6 Months 1 Year 2 Year

Company Profile bluebird bio is a company focused on the pursuit of curative gene therapies for severe genetic diseases. Co. has late-stage clinical and research programs for the treatment of sickle cell disease (SCD), ss-thalassemia and cerebral adrenoleukodystrophy and is developing research to apply new technologies to these and other diseases. Using a proprietary lentiviral vector platform, Co. custom designs each of its therapies to address the underlying cause of disease by introducing a functional copy of a gene to patients' own isolated hematopoietic stem cells. Co. is developing lovotibeglogene autotemcel as a one-time treatment for patients with SCD.

D/I:

D is for direct shares.
I is for indirect shares.

D/I refers to the Direct or Indirect shares traded vs. held.

Forms:

A Form 4 is a form filed by an insider to indicate a change in ownership.

A Form 3 is a form filed by an insider to indicate an initial ownership of a security.

3m +/-:

This represents the company's 3 month price change. The initial price is based on the closing price of the stock on the day the transaction took place. Purchases & sales are viewed as long & short positions respectively.

Actions:

B	Buy
S	Sell
OE	Option Exercised
A	Acquired
D	Disposed
AB	Automatic Buy
AS	Automatic Sell
IO	Initial Ownership

Download:

Download only Transactions Forms. (Default)

Download only Summary Infomation.

Download both Transactions and Summary Data

Summary (Direct Transactions Only)	3 Months	6 Months	12 Months	24 Months
Total Shares Bought	0	0	0	0
Total Buy Value	$0	$0	$0	$0
Total People Bought	0	0	0	0
Total Buy Transactions	0	0	0	0
Total Shares Sold	17,438	35,533	57,514	116,582
Total Sell Value	$26,639	$61,294	$139,194	$443,003
Total People Sold	3	5	5	9
Total Sell Transactions	3	9	12	23
End Date	2024-02-11	2023-11-10	2023-05-12	2022-05-12

Adjust Filter Settings

Records found: 939

Page 19 of 38

Filer's Name

Relation Title

Off-Dir-10%

D/I

Rank

3m +/-

Form

Chief Medical Officer

• – –

2017-11-01

4

OE

$5.50

$22,002

D/D

4,000

19,977

-

Walsh Jeffrey T.

Chief Financialand Strategy Of

• – –

2017-11-01

4

AS

$150.46

$5,298,326

D/D

(35,000)

27,305

-

Walsh Jeffrey T.

Chief Financialand Strategy Of

• – –

2017-11-01

4

OE

$5.50

$192,514

D/D

35,000

62,305

-

Gregory Philip D

Chief Scientific Officer

• – –

2017-11-01

4

AS

$144.10

$324,690

D/D

(2,250)

27,484

-

Gregory Philip D

Chief Scientific Officer

• – –

2017-11-01

4

OE

$50.51

$63,138

D/D

1,250

29,734

-

President and CEO

• • –

2017-10-23

4

AS

$145.26

$537,455

D/D

(3,700)

255,359

-

President and CEO

• • –

2017-10-20

4

AS

$145.02

$485,813

D/D

(3,350)

259,059

-

President and CEO

• • –

2017-10-17

4

AS

$145.05

$1,569,840

D/D

(10,823)

262,409

-

Walsh Jeffrey T.

Chief Financialand Strategy Of

• – –

2017-10-10

4

AS

$129.43

$636,724

D/D

(4,900)

27,305

-

Walsh Jeffrey T.

Chief Financialand Strategy Of

• – –

2017-10-10

4

OE

$5.50

$26,952

D/D

4,900

32,205

-

Gregory Philip D

Chief Scientific Officer

• – –

2017-10-02

4

AS

$131.82

$296,602

D/D

(2,250)

28,484

-

Gregory Philip D

Chief Scientific Officer

• – –

2017-10-02

4

OE

$50.51

$63,138

D/D

1,250

30,734

-

Chief Medical Officer

• – –

2017-10-02

4

AS

$130.37

$525,249

D/D

(4,000)

15,977

-

Chief Medical Officer

• – –

2017-10-02

4

OE

$5.50

$22,002

D/D

4,000

19,977

-

Hedley Mary Lynne

Director

– • –

2017-09-18

4

A

$0.00

$0

D/D

2,700

2,700

-

Maraganore John

Director

– • –

2017-09-14

4

S

$131.19

$2,475,733

D/D

(18,868)

5,843

-

Maraganore John

Director

– • –

2017-09-14

4

OE

$2.09

$39,434

D/D

18,868

24,711

-

Walsh Jeffrey T.

Chief Financialand Strategy Of

• – –

2017-09-11

4

AS

$125.44

$616,065

D/D

(4,900)

27,305

-

Walsh Jeffrey T.

Chief Financialand Strategy Of

• – –

2017-09-11

4

OE

$5.50

$26,952

D/D

4,900

32,205

-

Gregory Philip D

Chief Scientific Officer

• – –

2017-09-01

4

AS

$125.82

$283,635

D/D

(2,250)

29,484

-

Gregory Philip D

Chief Scientific Officer

• – –

2017-09-01

4

OE

$50.51

$63,138

D/D

1,250

31,734

-

Chief Medical Officer

• – –

2017-09-01

4

AS

$126.16

$1,548,904

D/D

(12,000)

15,977

-

Chief Medical Officer

• – –

2017-09-01

4

OE

$5.50

$66,005

D/D

12,000

27,977

-

President and CEO

• • –

2017-08-30

4

AS

$115.18

$2,956,307

D/D

(25,667)

313,701

-

Walsh Jeffrey T.

Chief Financialand Strategy Of

• – –

2017-08-28

4

AS

$107.06

$133,826

D/D

(1,250)

27,305

-

939 Records found	Previous 10 11 12 13 14 15 16 17 18 19 Next	Page 19 of 38

	Transaction Code Key:				Ownership Code Key
	B	- Buy	AB	- Automatic Buy	D	- Direct Ownership
	S	- Sell	AS	- Automatic Sell	I	- Indirect Ownership
	OE	- Options Exercised	A	- Acquired
	IO	- Initital Ownership	D	- Disposed

Copyright © 2024 j3sg.com | Disclaimer & Terms of use Products & Service About Us Contact Us

Summary:

Chart:

3m +/-:

This represents the company's 3 month price change. The initial price is based on the closing price of the stock on the day the transaction took place. Purchases & sales are viewed as long & short positions respectively.